Based on the available data, short-term effects related to MT-I and MT-II consist of the following [5, 18]: Nausea Facial flushing Fatigue Dizziness In addition, clinical studies on MT-II have reported several other specific side effects [19, 23]: Yawning Stretching Spontaneous erections Prolonged, painful erections (priapism) The administration of MT-I and MT-II can rarely cause reactions at the injection site, such as redness, swelling, and bleeding
Conclusion CKD is a progressive disease with increasing incidence, having very little success in current conventional therapies once CKD reaches stage 4
Ongoing care, per Omzo's published materials, includes access to the Omzo app for tracking progress, clinician-reviewed treatment plan adjustments, and ongoing support via the platform's care team
The medication was never the magic